Patents Assigned to Thomas C. Elder, Inc.
-
Patent number: 4298614Abstract: The invention relates to 5'-aminoalkyl-4',4-dialkylpsoralens having enhanced photosensitizing activity, especially oral activity, including early onset, increased maximum, and rapid decline, as well as low toxicity, when compared with psoralens of different structure.Type: GrantFiled: September 10, 1979Date of Patent: November 3, 1981Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4294847Abstract: The invention relates to 8-aminoalkyl-4-alkylisopsoralens, especially 8-aminomethyl-4-methylisopsoralen, having enhanced photosensitizing activity, especially oral and topical activity, pharmaceutical compositions thereof, and method of effecting photosensitization therewith.Type: GrantFiled: July 29, 1980Date of Patent: October 13, 1981Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4294822Abstract: The invention relates to 5'-aminoalkyl-4',4,8-trialkylpsoralens having enhanced photosensitizing activity, especially oral and topical activity, as well as low toxicity, when compared with psoralens of different structure.Type: GrantFiled: July 29, 1980Date of Patent: October 13, 1981Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4279922Abstract: The invention relates to 5-benzofuranacrylic acid compounds, preferably loweralkyl-substituted in the benzofuran ring system, which have photosensitizing activity, especially oral and topical activity, as well as low toxicity.Type: GrantFiled: July 29, 1980Date of Patent: July 21, 1981Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4269852Abstract: The invention relates to 4,5',8-trialkylpsoralens, having a substituent on the 4' carbon atom which is selected from hydroxyalkoxyalkyl and hydroxyalkylaminoalkyl, which are characterized by enhanced photosensitizing activity, especially oral activity, including comparable maxima, early onset, and especially rapid decline, as well as low toxicity, when contrasted with psoralens of different structure.Type: GrantFiled: September 10, 1979Date of Patent: May 26, 1981Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4269851Abstract: The invention relates to 8-aminoalkyl-4-alkylpsoralens having enhanced photosensitizing activity, especially oral activity, including early onset, increased maximum, and rapid decline, as well as low toxicity, when compared with psoralens of different structure.Type: GrantFiled: September 10, 1979Date of Patent: May 26, 1981Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4235781Abstract: .alpha.-Loweralkylfurocoumarins are produced by forming a .beta.-haloalk-2-enyl, e.g., .beta.-haloallyl, ether of a hydroxycoumarin having an active hydrogen in the position ortho to the hydroxy group, and heating the formed ether, preferably in dimethylaniline or like basic amine solvent. An abnormal Claisen rearrangement produces a novel o-hydroxy-(.beta.-haloalk-2-enyl) coumarin intermediate which can be dehydrohalogenated directly without isolation to the desired .alpha.-loweralkylfurocoumarin, e.g., .alpha.-methylfurocoumarin.Type: GrantFiled: September 20, 1979Date of Patent: November 25, 1980Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4216154Abstract: .alpha.-Loweralkylfurocoumarins are produced by forming a .beta.-haloalk-2-enyl, e.g., .beta.-haloallyl, ether of a hydroxycoumarin having an active hydrogen in the position ortho to the hydroxy group, and heating the formed ether, preferably in dimethylaniline or like basic amine solvent. An abnormal Claisen rearrangement produces a novel o-hydroxy-(.beta.-haloalk-2-enyl) coumarin intermediate which can be dehydrohalogenated directly without isolation to the desired .alpha.-loweralkylfurocoumarin, e.g., .alpha.-methylfurocoumarin.Type: GrantFiled: March 15, 1979Date of Patent: August 5, 1980Assignee: Thomas C. Elder, Inc.Inventor: Kurt D. Kaufman
-
Patent number: 4129576Abstract: 8-Methoxypsoralen is prepared in six steps from pyrogallol including condensation of pyrogallol with a two-fold excess of chloroacetic acid with boron trifluoride hydrogenation of 6,7-dihydroxy-2,3-dihydrobenzofuran and dehydrogenation of 2,3-dihydroxanthotoxin. Improvements in these three steps lead to a marked overall increase in yield.Type: GrantFiled: June 24, 1976Date of Patent: December 12, 1978Assignee: Thomas C. Elder, Inc.Inventors: Louis J. Glunz, Donald E. Dickson
-
Patent number: 4129575Abstract: 8-Methoxypsoralen is prepared in six steps from pyrogallol including hydrogenation of 6,7-dihydroxy-2,3-dihydrobenzofuran and dehydrogenation of 2,3-dihydroxanthotoxin. Improvements in these two steps lead to a marked overall increase in yield.Type: GrantFiled: April 12, 1976Date of Patent: December 12, 1978Assignee: Thomas C. Elder, Inc.Inventors: Louis J. Glunz, Donald E. Dickson
-
Patent number: RE30376Abstract: 8-Methoxypsoralen is prepared in six steps from pyrogallol including hydrogenation of .[.6,7-dihydroxy-2,3-dihydrobenzofuran.]. .Iadd.6,7-dihydroxycoumaranone .Iaddend.and dehydrogenation of .[.2,3.]. .Iadd.4',5'.Iaddend.-dihydroxanthotoxin. Improvements in these two steps lead to a marked overall increase in yield.Type: GrantFiled: August 20, 1979Date of Patent: August 19, 1980Assignee: Thomas C. Elder, Inc.Inventors: Louis J. Glunz, Donald E. Dickson
-
Patent number: RE30377Abstract: 8-Methoxypsoralen is prepared in six steps from pyrogallol including condensation of pyrogallol with a two-fold excess of chloroacetic acid with boron trifluoride hydrogenation of .[.6,7-dihydroxy-2,3-dihydrobenzofuran.]. .Iadd.6,7-dihydroxycoumaranone .Iaddend.and dehydrogenation of .[.2,3.]. .Iadd.4',5'.Iaddend.-dihydroxanthotoxin. Improvements in these three steps lead to a marked overall increase in yield.Type: GrantFiled: August 20, 1979Date of Patent: August 19, 1980Assignee: Thomas C. Elder, Inc.Inventors: Louis J. Glunz, Donald E. Dickson